Literature DB >> 8435662

T cell and NK cell mediated graft-versus-leukaemia reactivity following donor buffy coat transfusion to treat relapse after marrow transplantation for chronic myeloid leukaemia.

Y Z Jiang1, J O Cullis, E J Kanfer, J M Goldman, A J Barrett.   

Abstract

Two patients with chronic myeloid leukaemia in cytogenetic relapse following T lymphocyte-depleted BMT were treated with transfusions of donor buffy coat leucocytes. In both patients the marrow reverted to a completely normal karyotype and was negative for the BCR-ABL fusion gene transcript by polymerase chain reaction analysis. Before buffy coat transfusion the cytotoxic T lymphocyte precursor frequency against pre-BMT patient leukaemia cells (Lk-CTLP) was lower than that against pre-BMT patient PHA-transformed lymphocytes (Ly-CTLP) in both cases. At 2 weeks (case 1) and 8 weeks (case 2) after transfusion this ratio inverted so that Lk-CTLP predominated. Natural killer (NK) function fell initially and then recovered to exceed pre-transfusion values prior to normalization of the bone marrow karyotype. These changes in cytotoxic T lymphocytes and NK cells following donor buffy coat transfusions for patients with relapsed chronic myeloid leukaemia after marrow transplantation support the concept of a graft-versus-leukaemia effect mediated by both MHC restricted and non-restricted pathways.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8435662

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  5 in total

1.  The clinical implications of mixed lymphocyte reaction with leukemic cells.

Authors:  Hee-Je Kim; Tai-Gyu Kim; Hyun Il Cho; Hoon Han; Woo-Sung Min; Chun-Choo Kim
Journal:  Int J Hematol       Date:  2002-11       Impact factor: 2.490

2.  The antileukemia effect of HLA-matched NK and NK-T cells in chronic myelogenous leukemia involves NKG2D-target-cell interactions.

Authors:  Giuseppe Sconocchia; Michelle Lau; Maurizio Provenzano; Katayoun Rezvani; Wachanan Wongsena; Hiroshi Fujiwara; Nancy Hensel; Jos Melenhorst; Jonming Li; Soldano Ferrone; A John Barrett
Journal:  Blood       Date:  2005-07-26       Impact factor: 22.113

3.  T cells recognizing leukemic CD34(+) progenitor cells mediate the antileukemic effect of donor lymphocyte infusions for relapsed chronic myeloid leukemia after allogeneic stem cell transplantation.

Authors:  W M Smit; M Rijnbeek; C A van Bergen; W E Fibbe; R Willemze; J H Falkenburg
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-18       Impact factor: 11.205

4.  Recurrent extramedullary relapse of acute myelogenous leukemia after allogeneic hematopoietic stem cell transplantation in a patient with the chromosomal abnormality t(8;21) and CD56-positivity.

Authors:  Toshihiko Ando; Noriyuki Mitani; Kumiko Matsui; Koji Yamashita; Jun Nomiyama; Masatoshi Tsuru; Toshiaki Yujiri; Yukio Tanizawa
Journal:  Int J Hematol       Date:  2009-07-24       Impact factor: 2.490

5.  Nonmyeloablative stem cell transplantation as immunotherapy for kidney cancer and other metastatic solid tumors.

Authors:  Cristian Carvallo; Richard Childs
Journal:  Cytotechnology       Date:  2003-03       Impact factor: 2.058

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.